Trial intelligence / Profile preview

E2014 in Spasmodic Torticollis

NCT00165776Phase 2Completed

Sponsor
Eisai Co., Ltd.
Start
Jun 2004
Primary completion
May 2006
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type b in cervical dystonia (CD), sponsored by Eisai Co., Ltd.. Started Jun 2004; status: completed.

02

Drugs

botulinum toxin type b
03

Conditions

cervical dystonia (CD)

Beyond the preview

Go deeper on NCT00165776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00165776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call